Cleared Traditional

K213684 - SurgiCase Viewer

K213684 is the FDA 510(k) clearance for SurgiCase Viewer by Materialise NV. It is a Class 2 Radiology device (product code LLZ) cleared through the Traditional 510(k) pathway after a 205-day FDA review.

K213684 · Materialise NV · Radiology device
Download Printable Device Report (PDF)
Optimized for regulatory review, auditing and printing
Jun 2022
Decision
205d
Days
Class 2
Risk

K213684 is an FDA 510(k) clearance for the SurgiCase Viewer. Classified as System, Image Processing, Radiological within the LLZ classification (a category encompassing advanced image processing and PACS-adjacent software), Class II - Special Controls.

Submitted by Materialise NV (Leuven, BE). The FDA issued a Cleared decision on June 15, 2022 after a review of 205 days - an extended review cycle.

This device falls under the Radiology FDA review panel, regulated under 21 CFR 892.2050 - the FDA radiology and imaging software oversight framework. The Traditional 510(k) pathway establishes clearance through substantial equivalence to a legally marketed predicate device, without requiring clinical trial data.

Device pattern: Incremental AI imaging tool. Moderate-to-high equivalence dependency. Overall, this clearance reflects a predicate-aligned approval typical of modern AI radiology extensions - not a novel clinical breakthrough, but a validated iteration within an established regulatory category.

View all Materialise NV devices

Submission Details

510(k) Number K213684 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received November 22, 2021
Decision Date June 15, 2022
Days to Decision 205 days
Submission Type Traditional
Review Panel Radiology (RA)
Summary Summary PDF
Third-party Review No - reviewed directly by FDA
Combination Product No
PCCP Authorized No
Regulatory Context
Review time vs. panel average
98d slower than avg
Panel avg: 107d · This submission: 205d
Pathway characteristics
Predicate-based equivalence. No clinical trials required.

Device Classification

Product Code LLZ System, Image Processing, Radiological
Device Class Class 2 - Special Controls
CFR Regulation 21 CFR 892.2050
What this classification means

Class II devices require demonstration of substantial equivalence to a legally marketed predicate device. This pathway does not require clinical trials - it relies on engineering equivalence and performance data. Most Radiology devices follow this clearance model.

Regulatory Peers - LLZ System, Image Processing, Radiological

All 1092
Devices cleared under the same product code (LLZ) and FDA review panel - the closest regulatory comparables to K213684.
Axial3D Cloud Segmentation Service
K221511 · Axial Medical Printing Limited · Jun 2022
Syngo Carbon Space VA20A
K213665 · Siemens Healthcare GmbH · Jun 2022
ElucidVivo A.3
K221463 · Elucid Bioimaging, Inc. · Jun 2022
MediLab
K221065 · Sigma Scientific Services, LLC · Jun 2022
3D Anatomic Models
K220205 · Ricoh USA, Inc. · Jun 2022
EchoNavigator R4.0
K221270 · Philips Medical Systems Nederland B.V. · May 2022